 MALVERN, Pa., April 14, 2021 GLOBE NEWSWIRE -- Neuronetics, Inc. NASDAQ: STIM, a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that Brian Farley will retire from the Neuronetics Board of Directors and his role as Chairman following the companys Annual Meeting of Stockholders on May 27, 2021. Robert Cascella, who joined the Board of Directors on April 1, 2021, will be appointed as Chairman of its Board of Directors following Mr. Farleys retirement. Following Mr. Farleys retirement, the Board of Directors will have seven members. 